Gilead Sciences: confirmed distribution, but the double bottom in the 122 area demands attention

Gilead Sciences is at week 13 of the sell signal, with a 9.80% profit from entry. The last 4 weeks tell a story of progressively worsening distribution: MACD has turned negative, CMF has declined steadily, and momentum has accelerated to the downside. Against this reading, a double bottom in the 122 area has formed on the daily chart, with an intermediate rebound of 6%: a potential exhaustion signal worth monitoring closely.